Keiya Ozawa,
Professor Emeritus and Visiting Professor of the Division of Immuno-Gene & Cell Therapy
Keiya Ozawa received his M.D. from University of Tokyo in 1977 and his Ph.D. from University of Tokyo in 1984. After the residency in Internal Medicine at Tokyo University Hospital (1977-79), he became Research Associate of Jichi Medical School (1980-82) and University of Tokyo (1984-87). He studied at the Clinical Hematology Branch, NHLBI, NIH, USA as a Fogarty Fellow (1985-87). He became Assistant Professor in 1987 and then Associate Professor in 1990 of The Institute of Medical Science, The University of Tokyo (IMSUT). In 1994 he became Professor of the Institute of Hematology, Jichi Medical School. He was Professor and Chairman of the Division of Hematology, Department of Medicine (1998-2014) and Professor of the Division of Genetic Therapeutics, Center for Molecular Medicine (1998-2014). He was Director of Center for Molecular Medicine, Jichi Medical University (2008-14). He was also Professor of the Division of Immuno-Gene & Cell Therapy (Takara Bio), Jichi Medical University (2011-14). He was Director of IMSUT Hospital and Professor of the Division of Genetic Therapeutics, The Advanced Clinical Research Center, IMSUT (2014-18). He was also Director of Center for Gene & Cell Therapy (CGCT) of IMSUT (2014-18). In 2018, he became Professor Emeritus and Visiting Professor of the Division of Immuno-Gene & Cell Therapy (Takara Bio), Jichi Medical University. He is also Senior Adviser of the Center for Gene Therapy Research (CGTR), Jichi Medical University (2018- ). Dr. Ozawa has authored 470 original scientific and medical articles and 59 reviews and book chapters. Dr. Ozawa is a member of American Society of Hematology, American Society of Gene & Cell Therapy, European Hematology Association, European Society of Gene & Cell Therapy, The New York Academy of Sciences and so on.
|
|
